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To initiateanadaptive immune response, rare antigen-
specific naive CD4+ T cells must interact with equally
rare dendritic cells (DCs) bearing cognate peptide-
major histocompatibility complex (MHC) complexes.
Lymph nodes (LNs) draining the site of antigen entry
are populated by lymphoid-resident DCs as well as
DCs that have immigrated from tissues, although the
requirement for each population in initiating the T cell
response remains unclear. Here,we show that antigen
processing and presentation by both lymphoid-resi-
dent andmigratory DCswas required for clonal selec-
tion and expansionofCD4+T cells after subcutaneous
immunization. Early antigen presentation by lym-
phoid-resident DCs initiated activation and trapping
of antigen-specific T cells in the draining LN, without
sufficing for clonal expansion. Migratory DCs, how-
ever, interacted with the CD4+ T cells retained in the
LN to induce proliferation. Therefore, distinct DC sub-
sets cooperate to alert and trap the appropriate cell
and then license its expansion and differentiation.
INTRODUCTION
A rapid, antigen-specific immune response is essential for effec-
tive pathogen clearance. T cell activation is initiated by physical
interactions between naive T cells and antigen-presenting cells
(APCs) in secondary lymphoid structures. Naive T cells specific
for a given antigen are exceedingly rare (Moon et al., 2007), recir-
culating between the blood and lymph nodes (LNs) and spending
between a few hours to 1 day in any given LN (Cahill et al., 1976).
Both innate and antigen-specific signals enhance the retention
of T cells in the LN draining a site of inflammation. Innate signals
increase the influx of naive lymphocytes from the blood into in-
flamed LNs (Soderberg et al., 2005). Seminal work by Sprent
and colleagues demonstrated that antigen-specific T cell recir-
culation is then selectively halted early after immunization
(Sprent et al., 1971). Therefore, T cell ‘‘trapping’’ must be regu-
lated by T cell receptor (TCR)-dependent signals.
Peptide-major histocompatibility complex (MHC) class II
(MHCII) complexes on APCs stimulate CD4+ T cells. Activationof naive T cells also requires costimulation and cytokines, usually
provided by dendritic cells (DCs) in the T cell zone of secondary
lymphoid organs (Villadangos and Heath, 2005). With multiple
DC subsets in the draining LN, the minimally sufficient DC for
CD4+ T cell activation remains unclear. DCs can be subdivided
on the basis of surface-receptor expression or subdivided
according to their origin (Randolph et al., 2007). All secondary
lymphoid tissues, including the spleen, contain conventional
DCs that enter the organ as precursors via the bloodstream
(Naik et al., 2007). These lymphoid-resident DCs are positioned
in close proximity to LN conduits and rapidly take up and present
soluble antigen from lymph (Sixt et al., 2005). A second major
group of DCs are migratory DCs, which travel from tissues to
LNsvia theafferent lymphatics.MigratoryDCscarryhighconcen-
trations of processed antigen and accumulate in the LN paracor-
tex in the vicinity of high endothelial venules (HEVs); they do not
bind to conduits (Bajenoff et al., 2003; Sixt et al., 2005). The phys-
iologic functionofDCsmigrating from the skin remainscontrover-
sial. Blocking DC migration from the skin hinders CD4+ T cell ac-
tivation in response to subcutaneous antigen (Itano et al., 2003;
Ravindran et al., 2007; Van et al., 2006). However, cell-delivered
antigen is also impeded in these studies. Recent analysis of a viral
infection model proposed that migratory DCs simply carry intact
antigen to the draining LN (Allan et al., 2006). Thus, the necessity
for MHCII expression by DC populations remains unclear.
We examined the role for MHCII expression by various DC
subsets in the priming of CD4+ T cells to subcutaneous protein
antigen. Our data identify a requirement for direct antigen pre-
sentation by both lymphoid-resident and migratory DCs. Neither
lymphoid-resident nor migratory DCs alone were sufficient to
drive the early proliferation of naive CD4+ T cells. Initial antigen
presentation by lymphoid-resident DCs induced the upregula-
tion of CD69 and trapping of antigen-specific CD4+ T cells in
the inflamed draining LN. Sustained T cell activation and prolifer-
ation requiredmigratory-DC antigen presentation. Thus, multiple
DC subsets cooperate to activate naive T cells.
RESULTS
Migrating Radioresistant Cells Alone Cannot Prime
Naive CD4+ T cells
To probe the early in vivo requirements for DC priming of naive
CD4+ T cells, we tested the sufficiency of MHCII antigenImmunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc. 795
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DC Subsets Cooperate to Prime T cellspresentation restricted to particular DC subsets. We took advan-
tage of the different sensitivities of DC subsets to g-irradiation
and restricted antigen presentation to select DC populations.
Skin-draining LNs contain lymphoid-resident DCs and at least
two subsets of migratory DCs: dermal DCs and epidermal Lang-
erhans cells (LCs). Lymphoid-resident DCs derive from radio-
sensitive precursor(s) (Naik et al., 2007; Onai et al., 2007). In
contrast, epidermal LCs are a uniform population of DCs that de-
velop from local radioresistant precursors (Merad et al., 2002).
Thus, bone marrow (BM) chimeras can be utilized to experimen-
tally isolate a particular function to radioresistant skin DCs,
particularly LCs. Dermal DCs are a heterogeneous population,
including radioresistant and radiosensitive subsets (Bursch
et al., 2007; Ginhoux et al., 2007; Poulin et al., 2007; Shklovskaya
et al., 2008). Therefore, the radioresistant compartment also
includes a small fraction of dermal DCs (Bogunovic et al.,
2006).
Figure 1. Radioresistant APCs Do Not Efficiently Prime
T Cells In Vivo
(A) Purified CD4+ OT-II T cells (23 106) were CFSE labeled and adop-
tively transferred into WT/WT or H2-Ab1//WT chimeras 1 day
prior to subcutaneous immunization with 200 mg or 20 mg OVA protein
in CFA. CD4+CD90.1+Vb5+ cells in the draining LN were analyzed for
CFSE dilution by flow cytometry 7 days after immunization (n = 6).
Representative FACS plots are shown.
(B) BM chimeras were made with congenic CD45.2 donor and CD45.1
hosts. Cutaneous LNs were isolated from H2-Ab1//WT chimeras
7 days after immunization. DCs in the draining LN were analyzed
by flow cytometry for MHCII expression, gating on Langerinhi host
(CD45.1+), and Langerinlo donor (CD45.2+) DCs (solid) versus endog-
enous T cells (dashed). Representative data are shown.
(C) Radioresistant (CD45.1+) MHCII+ DCs were FACS sorted from the
cutaneous LNs of H2-Ab1//WT chimeras. Host DCs or control
irradiated WT splenocytes were incubated overnight with OVA protein
(100 mg/ml) and LPS (75 ng/ml). The next day, CFSE-labeled OT-II
cells (105) were added to decreasing numbers of antigen-loaded
APCs and cultured for 5 days. Representative FACS analyses of
CFSE dilution on CD4+CD90.1+Vb5+ OT-II cells are shown.
To test whether skin-DC antigen presentation was suf-
ficient to initiate CD4+ T cell priming, we restricted MHCII
expression to radioresistant cells. We generated H2-
Ab1//wild-type (WT) and WT/WT BM chimeras.
OT-II TCR transgenic T cells were transferred into BM chi-
meras 1 day prior to subcutaneous (s.c.) immunization
with OVA protein emulsified in complete Freund’s adju-
vant (CFA). Seven days after immunization, a majority of
OT-II cells in the draining LN had divided at least seven
times in control WT/WT BM chimeras, similar to unirra-
diated WT mice (Figure 1A; data not shown). Surprisingly,
MHCII expression on cutaneous DCs alone was not suffi-
cient to initiate proliferation of OT-II cells (Figure 1A). Even
large concentrations of antigen induced only minimal pro-
liferation (Figure 1A). The insufficiency of radioresistant
cells to prime naive T cells was also found with Ea-spe-
cific TEa TCR-transgenic CD4+ T cells after immunization
with cognate EaRFP protein (Figure S1 available online).
The defective T cell priming was not due to poor antigen
acquisition because epicutaneous immunization still did
not induce T cell proliferation in mice lacking functional MHCII
expression on lymphoid-resident DCs (Figure S1). The absence
of proliferation was also not secondary to chronic graft-versus-
host disease (GVHD) in H2-Ab1//WT chimeras, given that
we observed similar results in thymectomized H2-Ab1//WT
chimeras, which are protected from GVHD (Figure S1) (Sakoda
et al., 2007). Therefore, radioresistant APCs were not sufficient
to induce naive CD4+ T cell proliferation.
Given the lack of T cell proliferation in H2-Ab1//WT mice,
we examined the function of radioresistant APCs from cutane-
ous draining LNs in vitro. In H2-Ab1//WT chimeras, host-
derived radioresistant skin DCs (CD45.1+Langerinhi) present in
the draining LN were MHCII+ 7 days after immunization (Fig-
ure 1B). Conversely, radiosensitive lymphoid-resident CD8a+
DCs (CD45.2+Langerinlo) were MHCII negative (Figure 1B and
data not shown). Therefore, skin-derived host DCs that migrated
to the draining LN remained MHCII+. As shown in Figure 1C,796 Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc.
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antigen in vitro also retained the ability to induce naive OT-II cell
proliferation. Thus, fully functional radioresistant skin DCs were
present in the cutaneous draining LN, but they were insufficient
to activate naive CD4+ T cells in vivo.
Lymphoid-Resident DCs Cannot Mediate
Subcutaneous Priming
Radioresistant APCs were not sufficient to mediate CD4+ T cell
activation; therefore, MHCII expression on radiosensitive APCs
must be required. Skin-draining LNs contain two types of DCs:
lymphoid-resident and migratory. We have previously shown
that DCs in the spleen, which lacks migratory DCs, are sufficient
to prime naive CD4+ T cells to blood-borne antigen (Lemos et al.,
2003). Therefore, we asked whether lymphoid-resident-DC anti-
gen presentation in the LN could activate naive CD4+ T cells in
the absence of antigen presentation by migratory DCs.
We utilized a transgenic mouse model (CD11c-Ab
b mice), in
whichMHCII expression is targeted toCD11chiDCsofMHCII-de-
ficient mice (Lemos et al., 2003). Other professional APCs, such
as B cells and macrophages, lack detectable and functional
MHCII in CD11c-Ab
b mice. The lymphoid-resident DCs include
CD8a+ and CD8a subsets (Vremec et al., 2000). In CD11c-Ab
b
mice, both lymphoid-resident DC subsets express WT amounts
ofMHCII at steadystate andupregulateMHCII during skin inflam-
mation (Figure 2A; Figure S2). In contrast,migratory CD11clo DCs
Figure 2. Migratory DCs in CD11c-Ab
b Mice Function Poorly
(A) MHCII expression on lymphoid-resident DCs from spleens of WT, CD11c-Ab
b, or H2-Ab1/ mice was analyzed by flow cytometry: CD11c+CD8a+ (top) or
CD11c+CD8a (bottom) DC subpopulations.
(B and C) Ear skin fromWT, CD11c-Ab
b, or H2-Ab1/mice was physically separated into dermis and epidermis and cultured in GM-CSF-containing medium for
48 hr. Migratory cells isolated from these cultures were analyzed by flow cytometry for MHCII expression. Representative FACS plots are shown.
(B) CD11c+ dermal cells were gated on DEC205hiLangerinhi or DEC205intLangerinlo and analyzed for MHCII expression (n = 6).
(C) MHCII expression on epidermal CD45+CD11c+Langerin+ cells (n = 6).
(D and E) CD11c+ DCs from WT or CD11c-Ab
b mice were MACS sorted from LN or skin. The isolated DCs were incubated overnight with various doses of OVA
protein and LPS (75 ng/ml) and cultured with 105 CFSE-labeled OT-II cells for 5 days in vitro. Histograms of CFSE dilution of CD4+CD90.1+Vb5+ OT-II T cells are
shown (n = 3).
(D) OT-II T cell proliferation induced by 105 CD11c+ cutaneous LN DCs from WT (left) or CD11c-Ab
b (right) mice (n = 3).
(E) OT-II T cell proliferation induced by CD11c+ DC from dermal (103 or 104) or epidermal (105) explant cultures from WT or CD11c-Ab
b mice.Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc. 797
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b mice showed greatly reduced
MHCII expression compared toWTmice (Figure S2) (Kissenpfen-
nig et al., 2005). The lossofCD11cloMHCIIhi DCswasnot second-
ary to defective migration; function appeared normal except for
MHCII expression (Figure S2). These data are in agreement
with our previous studies observing low amounts of MHCII on
skin-derived FITC+ DCs in the LN (Lemos et al., 2003).
To more definitively characterize the DCs resident in the skin,
we analyzed mature DCs from skin explants. Dendritic cells
resident in the dermis of CD11c-Ab
b mice had greatly reduced
surface-MHCII expression compared with DCs from WT mice
(Figure 2B; Figure S3). More specifically, DEC205hiLangerinhi
DCs from CD11c-Ab
b mice expressed minimal MHCII, whereas
a fraction of DEC205intLangerinlo DCs expressed intermediate
amounts of MHCII. Additionally, mature LCs (CD45+CD11c+
DEC205hiLangerin+) from the epidermis of CD11c-Ab
b mice ex-
pressed barely detectable amounts of MHCII, unlike MHCIIhi LC
from WT mice (Figure 2C; Figure S3). Thus, MHCII expression is
largely restricted to lymphoid-resident DCs in CD11c-Ab
b mice.
Next, we tested whether DCs from CD11c-Ab
b mice could
present antigen. We purified CD11c+ cells from cutaneous LN
or skin explant cultures and pulsed themovernight with OVApro-
tein plus LPS. LN DCs from WT versus CD11c-Ab
b mice were
comparable in their driving of naive OT-II cell proliferation
in vitro (Figure 2D). These data are in agreement with our previ-
ous observation that T cell priming is normal in response to in-
traveous (i.v.) immunization (Lemos et al., 2003). Explant-derived
dermal and epidermal DCs from WT mice also promoted robust
proliferation of OT-II cells (Figure 2E). In contrast, neither dermal
nor epidermal DCs obtained from CD11c-Ab
b mice induced sig-
nificant proliferation of naive OT-II cells. Epidermal DCs were
completely devoid of the ability to induce OT-II proliferation,
and 104 dermal DCs induced minimal OT-II division compared
to WT dermal DCs. Therefore, migratory DCs from CD11c-Ab
b
mice are defective at MHCII-dependent antigen presentation.
The unique MHCII expression in CD11c-Ab
b mice allowed us
to test the sufficiency of lymphoid-resident DCs at priming naive
CD4+ T cells in vivo. CFSE-labeled OT-II CD4+ T cells were trans-
ferred into WT, CD11c-Ab
b, or H2-Ab1/ mice that were then
immunized with OVA emulsified in CFA. As observed in WT chi-
meras, the OT-II cells strongly proliferated in WT mice
(Figure 3A). Additionally, cell division was MHCII dependent. In
contrast, OT-II cells activated in CD11c-Ab
b mice had a severe
proliferative defect; a majority of the T cells remained undivided.
Proliferation of OT-II cells in CD11c-Ab
b mice immunized with 20
mg of antigen was comparable to that inWTmice immunizedwith
0.2 mg (Figures 3A and 3D; Figure S4). Thus, OT-II cells primed in
CD11c-Ab
b mice required 100-fold more antigen to initiate prolif-
eration. An early proliferation defect was also present when we
used TEa T cells in CD11c-Ab
b mice immunized with cognate
EaRFP protein (Figure S4). Although it remains possible that sub-
tle antigen-processing defects lead to poor T cell priming in
CD11c-Ab
b mice in vivo, our previous data demonstrate normal
T cell priming in response to i.v. immunization at multiple doses
of OVA protein (Lemos et al., 2003). Collectively, our data sug-
gest that MHCII expression restricted to lymphoid-resident
DCs is associated with poor in vivo priming of naive CD4+ T cells.
The reduced priming ability of lymphoid-resident DCs may be
secondary to insufficient numbers of MHCII+ DCs in the draining798 Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc.LN. Therefore, we treated WT, CD11c-Ab
b, and H2-Ab1/ ani-
mals with Flt3L to increase the number of conventional DCs in
lymphoid organs (Figure S4) (Mach et al., 2000). The priming
defect in CD11c-Ab
b mice persisted (Figure 3B). Naive T cells
recognizing the same antigen often compete for peptide-MHC
complexes on APC (Smith et al., 2000). Reducing the number
of adoptively transferred OT-II cells increases the T cell:DC ratio
in the draining LN (Catron et al., 2006). However, transferring 104
rather than 106 OT-II cells into CD11c-Ab
b mice only slightly
enhanced proliferation (Figure 3C). Therefore, decreasing the
competition for peptide-MHCII complexes did not substitute
for antigen presentation by migratory DCs.
The density of cognate peptide-MHC complexes on the sur-
face of DCs might be limiting on lymphoid-resident DCs. Naive
T cells may be more sensitive to changes in the density of pep-
tide-MHC complexes on the surface of individual DCs rather
than the number of antigen-bearing DCs in vivo. Indeed, 5-fold
more antigen results in almost full recovery of the T cell prolifer-
ative response in CD11c-Ab
b mice compared to WT mice (Fig-
ure 3D). There are two possible explanations for these data:
Lymphoid-resident DCs can prime T cells to large quantities of
antigen orMHCIIlo dermal DCs found in CD11c-Ab
bmice contrib-
ute in the priming at supraphysiologic antigen concentrations.
Nevertheless, our data suggest that neither lymphoid-resident
nor migratory DCs alone are efficient at presenting antigen to
naive T cells.
The Addition of Migratory-DC Antigen Presentation
Rescues T Cell Priming in CD11c-Ab
b Mice
Presentation of s.c. antigen in CD11c-Ab
b mice is remarkably
inefficient. This led us to hypothesize that restoring MHCII ex-
pression on migratory DCs may rescue the proliferation defect.
Again utilizing the radioresistant properties of a fraction of migra-
tory DCs, we generated BM chimeras with MHCII expressed
either exclusively on lymphoid-resident DCs (CD11c-Ab
b/
CD11c-Ab
b) or additionally on a migratory DC population
(CD11c-Ab
b/WT). As previously shown, WT control chimeras
(WT/WT) induced robust OT-II proliferation after s.c. immuni-
zation, whereas CD11c-Ab
b/CD11c-Ab
b chimeras displayed
defective OT-II cell priming (Figure 4A). In contrast, the addition
of antigen presentation by a radioresistant population in CD11c-
Ab
b/WT chimeras augmented the proliferation of antigen-
specific CD4+ T cells primed by lymphoid-resident DCs (Fig-
ure 4A). These results suggest that radioresistant cells express-
ing MHCII rescue the early proliferation defect observed in
CD11c-Ab
b mice.
To directly test whether the radioresistant APC rescuing the
proliferation defect in CD11c-Ab
b mice was indeed a migratory
DC, we generated BM chimeras with CCR7-deficient hosts. In
the absence of CCR7 expression, there is a profound defect in
the ability of migratory DC to emigrate to the LN after skin irrita-
tion (Forster et al., 1999). Lethally irradiated Ccr7+/ (WT) control
mice or CCR7-deficient mice were reconstituted with BM from
CD11c-Ab
bmice.When CD11c-Ab
b/Ccr7/micewere immu-
nized, OT-II cells had greatly reduced proliferation compared to
those in CD11c-Ab
b/WT mice (Figure 4B). Therefore, early
priming of naive CD4+ cells requires a migratory radioresistant
population to express MHCII in the draining LN.
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DC Subsets Cooperate to Prime T cellsFigure 3. Lymphoid-Resident DCs Poorly Prime Naive CD4+ T Cells
23 106 CFSE-labeled CD4+ OT-II T cells were adoptively transferred intoWT, CD11c-Ab
b, orH2-Ab1/mice 1 day prior to immunization with 20 mg OVA protein
in CFA. CD4+CD90.1+Vb5+ cells from the draining LN of indicated mice were analyzed for CFSE dilution by flow cytometry 4 days after immunization. Represen-
tative FACS plots are shown.
(A and B) CFSE dilution of OT-II T cells in the draining LNs of (A) untreated or (B) Flt3L-treated WT, CD11c-Ab
b, or H2-Ab1/ mice was determined (n = 3).
(C) Reduced numbers of congenic OT-II T cells (23 104) were adoptively transferred into WT or CD11c-Ab
b mice 1 day prior to subcutaneous immunization with
20 mg OVA protein in CFA. Proliferation of CD4+CD90.1+Vb5+ OT-II T cells in the draining LN was analyzed 4 days after immunization (n = 3).
(D) WT or CD11c-Ab
b mice were immunized with decreasing doses of OVA protein in CFA (200 mg, 100 mg, 20 mg, and 0 mg) 1 day after receiving 2 3 106
CFSE-labeled OT-II T cells. Histogram overlays represent CFSE dilution of congenic OT-II cells in draining LN of WT (line) or CD11c-Ab
b mice (gray shaded)
(n = 3).To attempt to identify the additive migratory radioresistant
population, we used congenic disparate hosts and donors to
mark the radioresistant compartment. Radioresistant MHCIIhi
cells in cutaneous LN contained both CD11cloLangerin+
CD103 cells and a small fraction of CD11cloLangerinCD103+
cells (Figure S5). When we compared DC populations present
in the cutaneous LN of CD11c-Ab
b mice and CD11c-Ab
b/WT
chimeras, roughly equivalent percentages of DC subsets were
observed based upon expression of Langerin and/or CD103
(Figure 4C). However, the low MHCII expression on a population
of Langerin+CD103lo cells in CD11c-Ab
b mice is restored in
CD11c-Ab
b/WT chimeras (Figure 4C). Therefore, the additive
migratory DCs found in CD11c-Ab
b/WT chimeras are likely
MHCIIhiLangerin+CD103lo.
To test whether migratory DCs also must process and present
antigens to be additive, we utilized H2-DM-deficient hosts to
block antigen presentation on radioresistant APCs without alter-ing MHCII expression levels. Lethally irradiated WT control mice
or H2-DM-deficient hosts were reconstituted with CD11c-Ab
b
BM. OT-II cell priming in CD11c-Ab
b/H2-DMa/ mice was
no different than the priming in unmanipulated CD11c-Ab
b
mice (Figure 4D). Indeed, both radiosensitive and radioresistant
DCs must process antigen because OT-II cells are also not
activated in H2-DMa//H2-DMa+/ chimeras. These data
suggest that direct antigen processing by migratory DCs was
necessary to rescue the proliferation defect observed in CD11c-
Ab
b mice.
Lymphoid-Resident and Migratory DCs Perform
Nonoverlapping Functions
The observations reported above indicate that naive CD4+ T cells
primed by either migratory or lymphoid-resident DCs alone do
not proliferate. To determine whether the T cells receive partial
stimulation, we examined TCR-dependent upregulation ofImmunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc. 799
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subunit of the interleukin-2Ra (IL-2Ra) chain. A time course of
CD69 expression on OT-II cells transferred into various mice is
shown in Figure 5. T cells activated in WT mice expressed
CD69 by 24 hrs, with peak expression at 48 hrs (Figure 5A).
The early T cell activation was MHCII- and antigen-dependent
Figure 4. Migratory Radioresistant APCs Rescue the T Cell Proliferative Defect Observed in CD11c-Ab
b Mice
2 3 106 CFSE-labeled CD4+ OT-II T cells were adoptively transferred into various BM chimeras 1 day prior to immunization with 20 mg OVA protein in CFA.
CD4+CD45.1+Vb5+ cells from the draining LN of indicated mice were analyzed for CFSE dilution by flow cytometry 4 days after immunization. Representative
FACS plots are shown.
(A and B) Representative FACS analysis of OT-II cell proliferation in the draining LN of (A) WT/WT, CD11c-Ab
b/WT, or CD11c-Ab
b/CD11c-Ab
b BM chimeras
and (B) CD11c-Ab
b/ CD11c-Ab
b, CD11c-Ab
b/Ccr7+/, or CD11c-Ab
b/Ccr7/ BM chimeras (n = 3).
(C) Flow-cytometry analysis comparing MHCII expression on CD11c+Langerin+ or CD11c+CD103+ cutaneous LN cells from CD11c-Ab
b or CD11c-Ab
b/WT
chimeras.
(D) Proliferation of CD4+ CD45.1+Vb5+ OT-II T cells in the draining LN of CD11c-Ab
b/H2-DMa+/, CD11c-Ab
b/H2-DMa/, or H2-DMa//H2-DMa+/ BM
chimeras 4 days after immunization.800 Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc.
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H2-Ab1/ mice or in WT mice immunized with CFA alone
(Figure 5A and data not shown). Priming in CD11c-Ab
b mice pro-
moted CD69 upregulation on OT-II cells with WT kinetics,
although there were statistically fewer CD69+ cells in the
CD11c-Ab
bmice (Figure 5A). In contrast, whenMHCII expression
was restricted to migratory DCs alone, OT-II cells lacked surface
CD69 at 48 hrs after immunization, suggesting that there is min-
imal interaction between naive OT-II cells and migratory DCs
(Figure 5B). Therefore, antigen presentation by lymphoid-resi-
dent DCs mediates the earliest events of T cell activation.
T cell proliferation correlates with expression of the a chain of
the IL-2 receptor (CD25). In OT-II cells primed in WT mice, CD25
expression peaks 48 hr after stimulation (data not shown). In
parallel, activated OT-II cells undergo blast transformation, as
shown by their increase in cell size (Figure 5D). In contrast,
very few OT-II cells activated in CD11c-Ab
b mice upregulated
CD25 (Figure 5C). In the absence of IL-2 signaling, the
CD69+OT-II cells in CD11c-Ab
b mice also remained small in
cell size (Figure 5D). The inability to induce CD25 expression
on lymphocytes is likely to be the proximate cause of the prolif-
Figure 5. Migratory DC Antigen Presentation
Mediates T Cell Progression into the Cell Cycle
(A) 2 3 106 CD4+ OT-II T cells were adoptively trans-
ferred into WT, CD11c-Ab
b, or H2-Ab1/ mice 1 day
prior to subcutaneous immunization with 20 mg OVA
protein in CFA. The percentage of OT-II cells
expressing CD69 in WT (-), CD11c-Ab
b (:), or H2-
Ab1/ mice ( ) was determined by FACS analysis
for 4 days after immunization. Standard deviation
(48 hrs) is of 3–5 mice per group (*p < 0.0001 WT
versus CD11c-Ab
b).
(B) 23 106 CFSE-labeled OT-II T cells were adoptively
transferred into WT/WT or H2-Ab1//WT chi-
meras. CD69 expression and CFSE dilution were
examined 48 hrs after immunization in the draining LN.
(C) 2 3 106 CD4+ OT-II T cells were adoptively trans-
ferred into WT, CD11c-Ab
b, or H2-Ab1/ mice 1 day
prior to immunization with 20 mg OVA protein in CFA.
The percentage of OT-II T cells in the draining LN ex-
pressing CD25 48 hrs after immunization was deter-
mined by flow cytometry. Standard deviation repre-
sents R6 mice per group (*p < 0.001 WT versus
CD11c-Ab
b).
(D) Purified OT-II cells were adoptively transferred into
WT or CD11c-Ab
b mice 1 day prior to immunization
with 20 mg of OVA protein in CFA. CD69 expression
and forward scatter of CD4+ CD45.1+Vb5+ OT-II cells
in the draining LN were analyzed by flow cytometry
48 hrs after immunization.
eration defect. Thus, antigen presentation by
lymphoid-resident DCs leads to upregula-
tion of CD69 without progression to CD25
expression and proliferation.
In our model, expression of CD69 required
antigen. Recent studies have demonstrated
that retention and egress of T cells in the
LN in response to type I interferon (IFN) is
partially regulated by CD69 inhibition of
sphingosine-1-phosphate (S1P) receptor re-
sponsiveness (Shiow et al., 2006). Antigen-specific lymphocytes
are selectively retained within the draining LN after delivery of
cognate antigen (Sprent and von Boehmer, 1976). Therefore,
we hypothesized that MHCII-dependent induction of CD69
might also regulate antigen-specific retention of naive CD4+
T cells. Equal numbers of CFSE-labeled antigen-specific
CD45.1+ OT-II cells and antigen-nonspecific CD90.1+ TEa cells
were adoptively transferred together into mice. WT mice,
CD11c-Ab
b mice, H2-Ab1/ mice, or H2-Ab1//WT chi-
meras were left untreated, immunized with CFA alone, or immu-
nizedwithOVA in CFA. The draining LNwas analyzed 42 hrs after
immunization, prior to cell division. In the absence of antigen,
there was no difference in the ratio of OT-II/TEa cells found in
the draining LN (Figure 6A). Thus, CFA differs from type I IFNs,
given that it does not induce nonspecific retention of CD4+
T cells in the draining LN. In contrast, WT and CD11c-Ab
b mice
immunized with OVA in CFA had a 2- to 3-fold increase in the ra-
tio of OT-II cells to antigen-nonspecific TEa cells in the draining
LN. No cell division had occurred at this time point in either T cell
population (Figure 6B). The ratio of OT-II/TEa cells in the draining
LN ofH2-Ab1//WT chimeras did not change and was similarImmunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc. 801
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sion on lymphoid-resident DCs induces the retention of antigen-
specific lymphocytes in the inflamed LN.
To determine whether cognate induction of CD69 by peptide-
MHCII complexes inversely correlates with S1P1-receptor ex-
pression, we measured S1P1 receptor mRNA from OT-II cells
sorted from WT or CD11c-Ab
b mice immunized with OVA in
CFA or WT mice treated with CFA alone. S1P1 receptor mRNA
levels were drastically reduced in OT-II cells from both WT and
CD11c-Ab
b mice 42 hrs after immunization (Figure 6C). There-
fore, antigen presentation by lymphoid-resident DCs induces
CD69 and mediates retention of antigen-specific T cells in the
draining LN.
DISCUSSION
We found that expansion of CD4+ T cells in cutaneous LNs
requires direct antigen presentation by two types of DCs—lym-
phoid-resident and migratory. Circulating rare antigen-specific
CD4+ T cells must be retained in the draining LN so that they
can interact with equally rare DCs presenting cognate ligands.
MHCII+ lymphoid-resident DCs trap useful T cell specificities
Figure 6. Antigen Presentation by Lymphoid-
Resident DC Regulates LN Trapping of Anti-
gen-Specific T Cells
(A) 2 3 105 CFSE-labeled CD45.1+ OT-II T cells and
2 3 105 CD90.1+ TEa T cells were cotransferred into
WT,CD11c-Ab
b,H2-Ab1/, andH2-Ab1//WTBM
chimeras 1 day prior to immunization in the left hind leg
with5mgOVA inCFA.42hrsafter immunization, theab-
solute number of antigen-specific (CD45.1+ OT-II) and
antigen-nonspecific (CD90.1+ TEa) CD4+ T cells in the
draining inguinal LN and the contralateral nondraining
axillary LN from the same animal were determined.
The ratio of OT-II/TEa cells in the draining LN is shown
with standard deviation representingR3 mice/group.
A representative experiment is shown (n = 3).
(B) Analysis of CFSE dilution of CD45.1+ OT-II cells
from the mice described in (A).
(C) Real-timePCR analysis of S1P1 receptormRNAex-
pression in OT-II cells sorted 42 hrs after immunization
with 20 mg OVA protein in CFA from draining LN of WT
or CD11c-Ab
b, aswell asWTmice immunizedwith only
CFA. Representative experiment is shown. Values rep-
resent mean ± SD of quadruplicate determinations,
normalized to GAPDH values.
in the draining LN until migratory DCs rein-
force initial T cell activation.
We exploited the restricted expression of
MHCII in the CD11c-Ab
b mouse and BM chi-
meras to establish that cooperation between
subsets of DCs is required to activate naive
CD4+ T cells. It has been reported that radio-
resistant host APCs in BM chimeras activate
neither alloreactive nor antigen-specific
CD8+ T cells (Allan et al., 2003; Shlomchik
et al., 1999; Sprent et al., 1971; Zhao et al.,
2003). In contrast, other groups have sug-
gested that a single DC subset may predom-
inate to activate CD4+ T lymphocytes. For example, antigen pre-
sentation of vaginal muscosal herpes simplex virus is focused to
a migratory dermal DC subset (Zhao et al., 2003). However,
these results derive from in vitro antigen-presentation assays,
in which we also find that single DC populations function nor-
mally. Separately, the effective T cell priming in both mice and
humans induced by cellular vaccination with antigen-loaded
DCs suggests that migratory DCs can prime naive T cells
(Tacken et al., 2007). However, Brocker and his colleagues
have clearly shown that an efficient T cell response to exogenous
DC vaccines requires MHCII expression by endogenous DCs
(Kleindienst and Brocker, 2003). Our results delineate unique
roles for multiple DC subsets during priming.
Allan and colleagues have proposed that migratory DCs func-
tion simply to deliver and transfer viral antigens to lymphoid-res-
ident DCs, which activate naive CD8+ T cells (Allan et al., 2006).
Recent studies from the same group suggest that a broader ar-
ray of DC subsets prime virus-specific CD4+ T cells (Mount et al.,
2008). This model prompted our analysis of the requirement for
antigen processing by different DC populations. Importantly,
our results with H2-DM-deficient mice as donors or hosts in
BM chimeras show that both radiosensitive and radioresistant802 Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc.
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transfer contributes to CD4+ T cell priming, the mechanism will
be complex, requiring both DC subsets.
Our data show that radioresistant, migratory APCs synergize
with inadequate antigen presentation in CD11c-Ab
b mice to
prime CD4+ T cells. Which APC cannot prime CD4+ T cells alone
but complements lymphoid-resident DCs? Themajor population
of MHCIIhi APCs in CD11c-Ab
b/WT chimeras is CD11cloLan-
gerin+, a phenotype previously identified as Langerhans cells
(Kissenpfennig et al., 2005). A model emphasizing the contribu-
tion of LCs to skin immune responses is counterintuitive in light of
recent literature. Studies have clearly demonstrated that dermal
DCs, rather than LCs, have a central role in the presentation of
antigens delivered subcutaneously (Itano et al., 2003; Mount
et al., 2008; Zhao et al., 2003). Indeed, ablation of Langerin+
APCs prior to immunization often has no effect on T cell re-
sponses (Stoitzner et al., 2008; Wang et al., 2008). Our results
demonstrate that these radioresistant APCs cannot alone prime
CD4+ T cells. It is possible that LCs that are neither necessary nor
sufficient for T cell priming can, nevertheless, synergize with lym-
phoid-resident radiosensitive DCs to prime CD4+ T cells. A sec-
ond possibility is that the additive MHCII+ APCs are dermal DCs.
Langerhans cells clearly overlap phenotypically with dermal
DCs. Some dermal DC are, like LCs, radioresistant (Bogunovic
et al., 2006; Shklovskaya et al., 2008), and both LCs and some
dermal DCs express the C-type lectin, Langerin. Finally, our
data are compatible with a model in which two dermal DC
populations—one radiosensitive in the CD11c-Ab
b mouse, the
second radioresistant—collaborate during T cell priming. Re-
gardless, a definitive role for two different populations of DCs,
at least one of which is migratory, has been demonstrated for
efficient T cell priming.
Our ability to distinguish the function of migratory and lym-
phoid-resident DCs is due to the unusual expression pattern of
MHCII in CD11c-Ab
b transgenic mice and the presence of radio-
resistant APCs in the skin. It will be important to establish
whether the paradigmwe have described applies to all T cell-de-
pendent immune responses or is unique to the skin. Recent work
in pulmonary systems suggests that DCs migrating from paren-
chyma are required for T cell responses (McGill et al., 2008). It is
not known whether the reverse is true—that lymphoid-resident
DCs are required for these responses. These experiments await
the identification of subset-specific promoters for control of
gene expression on radiosensitive lung (or other tissue) DC
subsets. It remains to be tested whether our results with skin
DCs apply broadly to other migratory DC subsets.
Activated CD4+ T cells sequentially alter expression of cell-
surface receptors; these phenotypic changes correlate with
qualitative and quantitative changes in T cell-DC interactions.
We found that CD69 is induced on naive T cells by lymphoid-
resident DCs. Itano and her colleagues also correlated CD69 ex-
pression with early access of soluble antigen in the LNs (Itano
et al., 2003). However, migratory DCs presenting high concen-
trations of antigen arrive just short of 1 day after immunization
or infection (Allan et al., 2006; Garg et al., 2003; Itano et al.,
2003; Kissenpfennig et al., 2005). During the intervening period,
antigen-specific T cells may egress from the draining LN. De-
pending upon the frequency of antigen-specific clones in the
repertoire, the T cell response could be drastically delayed.The trapping of antigen-specific lymphocytes is a mechanism
for retaining useful clonal specificities in the LN (Sprent et al.,
1971). The systemwe have described should permit a dissection
of the cellular requirements and chronology of these sequential
phases of T cell-DC interactions.
T cell egress from LNs is regulated by both chemokine and
S1P1 receptors. TCR-independent activation of lymphocytes
by type I IFNs induces upregulation of CD69, which then regu-
lates S1P1 responsiveness (Matloubian et al., 2004; Shiow
et al., 2006). In contrast, we found that CD69 expression on an-
tigen-specific CD4+ T cells required MHCII expression and anti-
gen. Therefore, innate activation by CFA must differ from type
I IFN signaling (Marta et al., 2008; Stenger and Modlin, 2002).
Antigen presentation by lymphoid-resident DCs was sufficient
to induce CD69 expression and decreased S1P1 receptor
mRNA expression after immunization. We demonstrated that
lymphoid-resident DCs selectively trap antigen-specific lympho-
cytes in the LN.
Why migratory DCs fail to induce delayed proliferation of OT-II
cells in the absence of lymphoid-resident-DC antigen presenta-
tion is still unclear. A mechanism for trapping antigen-specific
T cells, whose endogenous frequency is 1 in 105 cells, makes
sense. However, in adoptive-transfer models, this requirement
holds for both 104 and 106 transgenic T cells. At higher numbers
of T cells, undivided T cells can be detected in the draining LN,
and migratory DCs should be able to induce delayed T cell prim-
ing. This leads us to hypothesize that mature migratory DCs and
naive T cells cannot anatomically interact in the absence of initial
activation. Lymphoid-resident and migratory DCs localize differ-
ently within the LN (Bajenoff et al., 2003; Hickman et al., 2008;
Kissenpfennig et al., 2005; Sixt et al., 2005). Elegant imaging
work has demonstrated that naive T cellsmigrate along a stromal
network (Bajenoff et al., 2006). Lymphoid-resident DC are wrap-
ped around the stromal network in order to sample antigen in the
conduit (Sixt et al., 2005) and should be able to interact with the
naive T cells. Thus, T cells activated by lymphoid-resident DCs
may relocalize to permit selective interactions with migratory
DCs. Overall, the initial antigen presentation by lymphoid-resi-
dent DCs is a requisite step in T cell activation in vivo that func-
tions both to enrich antigen-specific T cells and to prime these
T cells for subsequent interactions with migratory DCs.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6, B6.129P2-Ccr7tm1Dgen/J, H-2DMatm1Luc, B6.PL-Thy1a/CyJ, B6.SJL-
PtpcrcaPep3b/BoyJ, and C57BL/6-Tg(TcraTcrb)425Cbn/J mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). H2-Ab1/ mice (Grusby
et al., 1991) were bred in our colony. The CD11c-Ab
b transgenic mouse has
been described previously (Lemos et al., 2003). B6.PL 3 TEa mice (Boonstra
et al., 2003) were a gift from Dr. M. Jenkins (University of Minnesota, Minneap-
olis, MN).
Mouse Treatments
Bone marrow transplantation methods were described previously (Merad
et al., 2002) (Table 1). Flt3L treatment involved injection of B16melanoma cells
secreting Flt3L for 10–12 days (Mach et al., 2000). Thymectomy was per-
formed with suction technique 3 weeks prior to use. All mice were housed un-
der pathogen-free conditions and used at 6–12weeks of age in all experiments
not involving BM chimeras. Mice were maintained and used in accordanceImmunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc. 803
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Chimera Name Radiosensitive Donor Radioresistant Host Phenotype
WT/ WT B6.SJL, C57Bl/6, H2-DM+/+,
H2-DM+/, or Ccr7+/ TCD BM
B6.SJL, C57Bl/6, H2-DM+/+,
H2-DM+/, or Ccr7+/
Wild-type MHCII expression
CD11c-Ab
b/ CD11c-Ab
b CD11c-Ab
b TCD BM CD11C-Ab
b MHCII only on lymphoid-resident DCs
CD11c-Ab
b/WT CD11c-Ab
b TCD BM B6.SJL, C57Bl/6, H2-DM+/,
Ccr7+/
MHCII on both lymphoid-resident
and migratory DCs
CD11c-Ab
b/ CCR7/ CD11c-Ab
b TCD BM Ccr7/ MHCII on both lymphoid-resident and migratory
DCs (radioresistant DCs defective in migration)
H2-Ab1//WT H2-Ab1/ TCD BM B6.SJL, C57Bl/6 MHCII only on migratory DCs
H2-DM// H2-DM+/ H2-DM/ TCD BM H2-DM+/ Wild-type MHCII expression
(radiosensitive DCs defective processing)
CD11c-Ab
b/ H2-DM/ CD11c-Ab
b TCD BM H2-DM/ TCD BM MHCII on both lymphoid-resident and migratory
DCs (radioresistant DCs defective in antigen
processing)
‘‘TCD BM’’ represents T cell-depleted bone marrow.with the University of Pennsylvania Institutional Animal Care and Use Guide-
lines.
Antibodies
I-Ab-FITC, Pacific Blue (Y3P), and DEC205-Alexa647 (NDLC-145) were all
conjugated in house (Invitrogen). All other antibody reagents were purchased
(BD Biosciences or eBiosciences). Intracellular staining was previously
described (Lemos et al., 2003). Samples were collected on a LSRII or FACS-
Calibur (BD Biosciences), and the data were analyzed with FlowJo software.
DC Isolation and Analysis
Lymph node DCs were isolated as previously described (Vremec and Short-
man, 1997). LCs and dermal DCs were obtained from epidermal or dermal
sheets of mouse ears as described previously (Ortner et al., 1996). The sepa-
rated epidermal and dermal sheets were incubated for 48 hr in completemedia
in the presence of 10% GM-CSF supernatant (B78H1-GM-CSF cell line,
courtesy of H. Levitsky, Johns Hopkins). Skin inflammation and painting
were performed as previously described (Lemos et al., 2003).
CD4 T Cell Purification and Analysis
CD4+ T cells were isolated from spleen and peripheral LN by negative selection
with antibody supernatants (2.4G2, 2.43, M5/114, RA3-6B2) followed with
goat anti-rat IgG magnetic beads (QIAGEN) for isolation of CD4+ T cells.
CFSE (Invitrogen) labeling of CD4+ T cells was previously described (Lemos
et al., 2003). For in vivo experiments, OT-II or TEa CD4+ T cells were i.v. trans-
ferred.
Immunization
Mice were s.c. immunized at four injection sites (shoulders and hind legs)
receiving a combined 20mg, 100ug, or 200mg OVA protein (Sigma-Aldrich) or
EaRFP (Itano et al., 2003) emulsified 1:1 (v/v) in CFA (Sigma-Aldrich). Trapping
experiments involved immunization only in the left hind leg with 5 ug OVA in
CFA. OTII or TEa T cell activation in draining LN was analyzed by flow cytom-
etry. Topical skin immunization was performed as previously described (Bynoe
et al., 2003). In brief, 2 3 106 purified CFSE-labeled OT-II CD4+ T cells were
adoptively transferred. The back skin was shaved with an electric razor. One
day later, 100 mg OVA protein and 500 mg ODN-1826 in 100 ml PBS were ap-
plied to the back and covered with an occlusive patch. Control mice were
treated with ODN-1826 alone. The patch was left in place for 1 week. Drain-
ing-LN T cells were analyzed for CFSE dilution by flow cytometry.
Quantitative Real-Time Polymerase Chain Reaction
Total RNA was extracted from cells sorted directly into Trizol LS Reagent (In-
vitrogen). RNAwas reverse-transcribedwith random hexamers. An ABI PRISM
7500 machine was used for quantitative real-time PCR according to the man-
ufacturer’s instructions (Applied Biosystems). Presynthesized Taqman Gene
Expression Assays (Applied Biosystems) were used to amplify the following804 Immunity 29, 795–806, November 14, 2008 ª2008 Elsevier Inc.sequences (gene symbols and Applied Biosystems primer set numbers
appear in parentheses): mouse S1P1 receptor (Edg1; Mm02619656_s1) and
mouse GAPDH (gapdh; Mm99999915_g1). ‘‘Test’’ gene values are expressed
relative to that of GAPDH, with the lowest experimental value standardized
at one.
Statistics
Statistical analysis used the Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
at http://www.immunity.com/supplemental/S1074-7613(08)00457-3.
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